| Dr Robert Hawes Bartlett, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-5822 | |
| (734) 615-4220 |
| Full Name | Dr Robert Hawes Bartlett |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952603730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 4301026234 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Hawes Bartlett, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-5822 | Dr Robert Hawes Bartlett, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-5822 |
News Archive
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
The perennial stress-buster - a deep breath - could become stress-detector, Loughborough University researchers claim. According to a new pilot study, published today, 28 February, in IOP Publishing's Journal of Breath Research, there are six markers in the breath that could be candidates for use as indicators of stress.
Evolutionary theorist Alastair Clarke has published details of eight patterns he claims to be the basis of all the humour that has ever been imagined or expressed, regardless of civilization, culture or personal taste.
Could the answer to repairing the ailing placenta in preeclampsia lie within the stem cells of a healthy placenta? New promising evidence may lead scientists to answer that question.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive clinical results from its Phase I trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis.
› Verified 1 days ago
John C Magee, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Steven W Bruch, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr., 4th Floor, C.s. Mott Children's Hospital, Ann Arbor, MI 48109 Phone: 734-764-4151 | |
Theodore Hobart Welling, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 2nd Floor Taubman Ctr Recp F, Ann Arbor, MI 48109 Phone: 734-936-5738 | |
Eiichi A Miyasaka, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Department Of Surgery, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Nathan Louras, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Robert J Beaulieu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Meredith Barrett, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |